Institutions
Institute for Oncology and Radiology of Serbia
The Institute for Oncology and Radiology of Serbia (IORS) was founded in 1939. and has since remained the only comprehensive cancer center in Serbia. We promote the application of scientific, technological, and biomedical achievements and the implementation of state-of-the-art protocols for prevention, diagnosis, treatment, supportive therapy, psycho-social support, and palliative care in Serbia. Around 1000 dedicated medical and scientific staff are employed at IORS, which is composed of Clinics for Radiological Diagnostics, Radiotherapy, Oncological Surgery, Medical Oncology, Pediatric Oncology, Pathohistology and Cytology, Epidemiology, Clinical Trials Sector, and Experimental Oncology Department with molecular diagnostic service. IORS is also an educational base for Oncology, as a part of the Faculty of Medicine, University of Belgrade, Serbia.
At IORS, we work guided by the vision of applying science to provide superior health care that includes prevention, early detection, personalized therapy, and comprehensive care and support to patients and their families.
Institute for Oncology and Radiology of Serbia
The Institute for Oncology and Radiology of Serbia (IORS) was founded in 1939. and has since remained the only comprehensive cancer center in Serbia. We promote the application of scientific, technological, and biomedical achievements and the implementation of state-of-the-art protocols for prevention, diagnosis, treatment, supportive therapy, psycho-social support, and palliative care in Serbia. Around 1000 dedicated medical and scientific staff are employed at IORS, which is composed of Clinics for Radiological Diagnostics, Radiotherapy, Oncological Surgery, Medical Oncology, Pediatric Oncology, Pathohistology and Cytology, Epidemiology, Clinical Trials Sector, and Experimental Oncology Department with molecular diagnostic service. IORS is also an educational base for Oncology, as a part of the Faculty of Medicine, University of Belgrade, Serbia.
At IORS, we work guided by the vision of applying science to provide superior health care that includes prevention, early detection, personalized therapy, and comprehensive care and support to patients and their families.
The Netherlands Cancer Institute Antoni van Leeuwenhoekziekenhuis
The Netherlands Cancer Institute Antoni van Leeuwenhoekziekenhuis (NKI AVL) is among the world’s best comprehensive cancer centers, combining innovative fundamental, translational, and clinical research with dedicated patient care. Our research institute gratefully acknowledges funding from the Dutch Ministry of Health, Welfare, and Sport, the Dutch Cancer Society, and individual donors. The NKI AVL offers a motivating, interactive, and supportive environment in which people from various fields of expertise work together. We are committed to training the next generation of leaders in the field of cancer research.
Around 600 scientists are currently working at the NKI AVL, together with approximately 150 scientific and 150 administrative support staff members. Our research unites many different disciplines; the full spectrum – from basic research to clinical research. The NKI AVL is embedded in several (inter)national scientific networks, providing easy access to a broad range of institutes, technologies, and expertise.
The Netherlands Cancer Institute Antoni van Leeuwenhoekziekenhuis
The Netherlands Cancer Institute Antoni van Leeuwenhoekziekenhuis (NKI AVL) is among the world’s best comprehensive cancer centers, combining innovative fundamental, translational, and clinical research with dedicated patient care. Our research institute gratefully acknowledges funding from the Dutch Ministry of Health, Welfare, and Sport, the Dutch Cancer Society, and individual donors. The NKI AVL offers a motivating, interactive, and supportive environment in which people from various fields of expertise work together. We are committed to training the next generation of leaders in the field of cancer research.
Around 600 scientists are currently working at the NKI AVL, together with approximately 150 scientific and 150 administrative support staff members. Our research unites many different disciplines; the full spectrum – from basic research to clinical research. The NKI AVL is embedded in several (inter)national scientific networks, providing easy access to a broad range of institutes, technologies, and expertise.
The Biomedical Research Foundation of the Academy of Athens
The Biomedical Research Foundation of the Academy of Athens (BRFAA) is the most recent addition to the Life Sciences Research organizations in Greece, which began its activities in 2004. The founding principle of BRFAA is to host both basic and clinical research, thus, providing an ideal setting for the emergence of translational activities (Medical Application). BRFAA is one of the few institutes with such character in Europe and is certainly unique for Greece. The main goal of BRFAA is to achieve excellence in the Biomedical Sciences by recruiting high-quality investigators to carry out cutting-edge basic and translational research and by training young researchers in state-of-the-art facilities, which provide a particularly stimulating scientific environment and strong research infrastructures.
At present, BRFAA consists of 4 Research Centers (Institutes) specialized in different aspects of Biomedical Research focusing on the following research areas: gene regulation, stem cells, neurobiology, developmental biology, aging, cancer, inflammation, stress and metabolic syndromes, cardiovascular pathophysiology and environmental health issues.
These research activities are being pursued in the context of the following Centers: (1) Center of Basic Research, (2) Center of Clinical and Translational Research, and Experimental Surgery (3) Center of Systems Biology, and (4) Center of Environmental Health.
The Biomedical Research Foundation of the Academy of Athens
The Biomedical Research Foundation of the Academy of Athens (BRFAA) is the most recent addition to the Life Sciences Research organizations in Greece, which began its activities in 2004. The founding principle of BRFAA is to host both basic and clinical research, thus, providing an ideal setting for the emergence of translational activities (Medical Application). BRFAA is one of the few institutes with such character in Europe and is certainly unique for Greece. The main goal of BRFAA is to achieve excellence in the Biomedical Sciences by recruiting high-quality investigators to carry out cutting-edge basic and translational research and by training young researchers in state-of-the-art facilities, which provide a particularly stimulating scientific environment and strong research infrastructures.
At present, BRFAA consists of 4 Research Centers (Institutes) specialized in different aspects of Biomedical Research focusing on the following research areas: gene regulation, stem cells, neurobiology, developmental biology, aging, cancer, inflammation, stress and metabolic syndromes, cardiovascular pathophysiology and environmental health issues.
These research activities are being pursued in the context of the following Centers: (1) Center of Basic Research, (2) Center of Clinical and Translational Research, and Experimental Surgery (3) Center of Systems Biology, and (4) Center of Environmental Health.
Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer
In 1989, we created the Fundació de Recerca Clínic Barcelona (FRCB) the first Foundation in Spain devoted to promoting and managing research independently from healthcare. In 1996, the August Pi Sunyer Biomedical Research Institute (IDIBAPS) was founded, as a public consortium comprising the Hospital Clínic de Barcelona, the University of Barcelona, and the Government of Catalonia, with the CSIC Institute of Biomedical Research in Barcelona later joining as an associated center.
The consortium’s aim is to integrate basic and clinical research in order to attempt to answer questions that arise whilst caring for our patients. This healthcare, teaching, and university environment, in which basic, translational, and clinical research is carried out, comprising the Hospital, the Foundation, IDIBAPS and the Faculty of Medicine and Health Sciences of the University of Barcelona, form the Barcelona Clínic Campus, a flagship biomedical research center in Catalonia and in Spain for ongoing research into diseases and their treatment, clinical applications and their dissemination. On January 1, 2023, the unification of the scientific and management activities of IDIBAPS and FRCB became effective, producing the current joint entity Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS).
Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer
In 1989, we created the Fundació de Recerca Clínic Barcelona (FRCB) the first Foundation in Spain devoted to promoting and managing research independently from healthcare. In 1996, the August Pi Sunyer Biomedical Research Institute (IDIBAPS) was founded, as a public consortium comprising the Hospital Clínic de Barcelona, the University of Barcelona, and the Government of Catalonia, with the CSIC Institute of Biomedical Research in Barcelona later joining as an associated center.
The consortium’s aim is to integrate basic and clinical research in order to attempt to answer questions that arise whilst caring for our patients. This healthcare, teaching, and university environment, in which basic, translational, and clinical research is carried out, comprising the Hospital, the Foundation, IDIBAPS and the Faculty of Medicine and Health Sciences of the University of Barcelona, form the Barcelona Clínic Campus, a flagship biomedical research center in Catalonia and in Spain for ongoing research into diseases and their treatment, clinical applications and their dissemination. On January 1, 2023, the unification of the scientific and management activities of IDIBAPS and FRCB became effective, producing the current joint entity Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS).
